IRS-1: Auditing the effectiveness of mTOR inhibitors

被引：61

作者：

Easton, JB ^{[1
]}

Kurmasheva, RT ^{[1
]}

Houghton, PJ ^{[1
]}

机构：

[1] St Jude Childrens Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA

来源：

CANCER CELL | 2006年 / 9卷 / 03期

关键词：

D O I：

10.1016/j.ccr.2006.02.027

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：153 / 155

页数：3

共 16 条

[1] The TOR pathway: A target for cancer therapy [J].

Bjornsti, MA ;

Houghton, PJ .

NATURE REVIEWS CANCER, 2004, 4 (05) :335-348

[2] A signaling pathway to translational control [J].

Brown, EJ ;

Schreiber, SL .

CELL, 1996, 86 (04) :517-520

[3] Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex [J].

Brugarolas, J ;

Lei, K ;

Hurley, RL ;

Manning, BD ;

Reiling, JH ;

Hafen, E ;

Witter, LA ;

Ellisen, LW ;

Kaelin, WG .

GENES & DEVELOPMENT, 2004, 18 (23) :2893-2904

[4] RETRACTED: Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin (Retracted Article) [J].

Dan, HC ;

Sun, M ;

Yang, L ;

Feldman, RI ;

Sui, XM ;

Ou, CC ;

Nellist, M ;

Yeung, RS ;

Halley, DJJ ;

Nicosia, SV ;

Pledger, WJ ;

Cheng, JQ .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (38) :35364-35370

[5] A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1 [J].

Haruta, T ;

Uno, T ;

Kawahara, J ;

Takano, A ;

Egawa, K ;

Sharma, PM ;

Olefsky, JM ;

Kobayashi, M .

MOLECULAR ENDOCRINOLOGY, 2000, 14 (06) :783-794

[6] The Akt-mTOR tango and its relevance to cancer [J].

Hay, N .

CANCER CELL, 2005, 8 (03) :179-183

[7] mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events [J].

Holz, MK ;

Ballif, BA ;

Gygi, SP ;

Blenis, J .

CELL, 2005, 123 (04) :569-580

[8]

Hosoi H, 1999, CANCER RES, V59, P886

[9] TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling [J].

Inoki, K ;

Li, Y ;

Zhu, TQ ;

Wu, J ;

Guan, KL .

NATURE CELL BIOLOGY, 2002, 4 (09) :648-657

[10] Mutations in the PI3K/PTEN/TSC2 pathway contribute to mammalian target of rapamycin activity and increased translation under hypoxic conditions [J].

Kaper, F ;

Dornhoefer, N ;

Giaccia, AJ .

CANCER RESEARCH, 2006, 66 (03) :1561-1569

← 1 2 →